Soluble plasma HLA peptidome as a potential source for CHB biomarkers

Affiches Jul 29, 2019
Maladies infectieuses
|
Spectrométrie de masse, Protéomique

July 29, 2019

Diana Chen, Ruidong Li, Eustache Paramithiotis, Gwen Pottiez, Ross Martin, Xinan Liu, Jenny Svarovskaia, Hongmei Mo, Li Li, Anuj Gaggar, Jeffrey Wallin

Soluble plasma HLA peptidome as a potential source for CHB biomarkers, AASLD 2019

Soluble plasma HLA peptidome as a potential source for CHB biomarkers

Featured Resources

See All Experts' Insights
WRIB 2 Affiches
Apr 14, 2026

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS
Picture5 Brochure
Apr 3, 2025

Biomarker strategies to support success at every stage of therapy development
Proteomic Assay List Brochure
Jun 4, 2024

Proteomic Assay List
See All Experts' Insights

One global CRO for your whole therapeutic development journey

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Talk to our Team
cta banner